Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced its upcoming ...
An online archive of the webcast will be available within one hour of the conclusion of the webcast and will remain available until April 12, 2025 on our investor relations website provided above.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback